MTIF 2018 Highlights

OCTANe CEO Bill Carpou opens up the 2019 Medical Technology Innovation Forum with a focus on the current MedTech ecosystem in Southern California and what the future holds for growth in Orange County

Dr. Anthony Chang- Chief Intelligence & Innovation Officer, CHOC

Better diagnoses, earlier interventions, more-efficient drug therapies, customized treatment plans. These are the promises of personalized medicine. Individualized, precision or personalized medicine provides a genomic blueprint to determine each person’s unique disease susceptibility, define preventive measures and enable targeted therapies to promote wellness. Our panelists will provide their unique perspectives on what the future holds for personalized medicine.

Steve Keiles, Senior Director, Genomic Services, Advanced Diagnostics, Quest Diagnostics

Patrick Lilley, Founder & CEO, Liquid Biosciences

Annette Walker, President, City of Hope

Shaista Malik, MD, PhD, MPH, Associate Vice Chancellor, Integrative Health & Executive Director, Susan Samueli Integrative Health Institute

An update on current status of BREXIT. What does BREXIT mean for companies in the US and Britain? What are the tax and legal implications? What are the implications for doing business in the rest of Europe?

Kevin Depew, Deputy Chief Economist, RSM- Moderator

Mike Howells, Consul General, British Consulate

Alison Dennis, Partner, Field Fisher

Patrick Johnson, President & CEO, Celluma

Through research he explores the way genetic and perinatal environmental factors affect the way the brain gets built — and then how an individual’s experience further shapes his or her development.  But has Fallon’s research on psychopaths and murderers made a strange and personal turn.  With PET scans and genetics , he uncovered  the deep, underlying traits that make people violent and murderous.

This session will focus on the the challenges of doing business in China: avoiding the pitfalls and how to find trusted partners while doing business in the country.

John Cox, President & CEO, FRESCA Medical (Moderator)

Chris Lo, Director, Hong Kong Trade Development Council

Jim Mayfield, Director, US Export Assistance Center

Paul DeRidder, MD, MBA, President, BioValleyCHINA

Andrew Pan, Senior Vice President & Head, East West Bank’s   China Business & Strategy

Healthcare varies around the world with almost all wealthy nations providing universal health care (the US is an exception).  Due to the costs required as well as various social, cultural, political and economic conditions, healthcare is challenging to get right. Learn from other countries about how their healthcare systems are evolving and what innovative steps are they taking. Learn  about  the landscape for MedTech start-ups and companies doing business in other countries and  the advantages to being based outside the United States and what opportunities are there available.

Linda DiMario, Executive Vice President, Irvine Chamber

Panelists in this session will facilitate the exchange of insights on emerging trends and innovation in medical aesthetics.

Dr. Scott Whitcup, Founder and CEO, Akrivista and Whitecap Biosciences (Moderator)

Dr. Edward Ross, Scripps

Dr. Chris Zachary, Chair & Professor – Dermatology, UC Irvine School of Medicine

Dr. Natasha Mesinkovska, Dermatology Specialist, UC Irvine Medical Center

Dr. Steve Yoelin, Cosmetic Surgeon

Darin Messina, Vice President of Device Biology R&D, Allergan

Despite its controversial nature, medical marijuana use and legal adoption continues to expand nationwide. Currently, there are over 70 completed or ongoing human clinical trials exploring cannabinoid use. However, many questions remain as variations of legal use exist from state to state, and more data is necessary to determine its clinical benefit and global effect on the United States health care system.

Kim Kovacs, President, Los Angeles Venture Association (LAVA), & CEO, MyJane (Moderator)

Dan Torpey, Partner, EY